Impulse control disorders: Updated review of clinical characteristics and pharmacological management

Frontiers in Psychiatry

Volumn 2, Issue FEB, 2011, Pages

  Schreiber, Liana ^a   Odlaug, Brian L ^a   Grant, Jon E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Clinical characteristics; Impulse control disorders; Pharmacotherapy

Indexed keywords

ACETYLCYSTEINE; AMFEBUTAMONE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; LAMOTRIGINE; LITHIUM CARBONATE; LITHOBID SR; NALMEFENE; NALTREXONE; OLANZAPINE; PAROXETINE; PLACEBO; SERTRALINE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

AGE DISTRIBUTION; ANXIETY DISORDER; BIOLOGICAL TRAIT; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; COMPLUSIVE BUYING DISORDER; COMPULSION; COMPULSIVE BUYING DISORDER; COMPULSIVE SEXUAL BEHAVIOR; DRUG EFFICACY; DSM-IV; GENETIC TRAIT; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; INTERMITTENT EXPLOSIVE DISORDER; KLEPTOMANIA; MALADJUSTMENT; MEDICAL RESEARCH; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PATHOLOGICAL GAMBLING; PATHOLOGICAL SKIN PICKING; PHENOMENOLOGY; PYROMANIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECREATION; REVIEW; SELF ESTEEM; SEX DIFFERENCE; SEXUAL BEHAVIOR; TREATMENT DURATION; TREATMENT RESPONSE; TRICHOTILLOMANIA; VISUAL ANALOG SCALE;

EID: 84861458725     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2011.00001     Document Type: Review

References (93)

1. American Psychiatric Association. (2000). Diagnositic and Statistical Manual of Mental Disorders, 4th Edn, Text-Revised: DSM-IV-TR. Washington, DC: Ame r i c an Psychiatric Publishing, Inc.
2. American Psychiatric Association. (2010). DSM-5 Development. Available at: http://www.dsm5.org/ ProposedRevisions/Pages/Impulse-ControlDisordersNotElsewhereClassified.aspx (accessed October 12, 2010).
3. Arbabi, M., Farina, V., Balighi, K., Mohammadi, M. R., Nejati-Safa, A. A., Yazdchi, K., Golestan, B., and Darvish, F. (2008). Efficacy of citalopram in treatment of pathological skin picking: a randomized double blind placebo controlled trial. Acta Med. Iran 46, 367-372.
4. Arieff, A. J. B., and Bowie, C. G. (1947). Psychiatric aspects of shoplifting. Arch. Neurol. Psychiatry 57, 777-778.
5. Arnold, L. M., Auchenbach, M. B., and McElroy, S. L. (2001). Psychogenic excoriation: clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 15, 351-359.
6. Arnold, L. M., McElroy, S. L., Mutasim, D. F., Dwight, M. M., Lamerson, C. L., and Morris, E. M. (1998). Characteristics of 34 adults with psychogenic excoriation. J. Clin. Psychiatry 59, 509-514.
7. Black, D. W. (2007). A review of compulsive buying disorder. World Psychiatry 6, 14-18.
8. Black, D. W., Arndt, S., Coryell, W. H., Argo, T., Forbush, K. T., Shaw, M. C., Perry, P., and Allen, J. (2007). Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebocontrolled, flexible-dose study. J. Clin. Psychopharmacol. 27, 143-150.
9. Black, D. W., Gabel, J., Hansen, J., and Schlosser, S. (2000). A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Ann. Clin. Psychiatry 12, 205-211.
10. Black, D. W., Kehrberg, L. L. D., Flumerfelt, D. L., and Schlosser, S. S. (1997). Characteristics of 36 subjects reporting compulsive sexual behavior. Am. J. Psychiatry 154, 243-249.
11. Black, D. W., Repertinger, S., Gaffney, G., and Gabel, J. (1998). Family history and psychiatric comorbidity in persons with compulsive buying: preliminary findings. Am. J. Psychiatry 155, 960-963.
12. Blanco, C., Petkova, E., Ibáñez, A., and Sáiz-Ruiz, J. (2002). A pilot placebocontrolled study of fluvoxamine for pathological gambling. Ann. Clin. Psychiatry 14, 9-15.
13. Blaszczynski, A., and Steel, Z. (1998). Personality disorders among pathological gamblers. J. Gambl. Stud. 14, 51-71.
14. Bloch, M. R., Elliott, M., Thompson, H., and Koran, L. M. (2001). Fluoxetine in pathologic skin-picking: openlabel and double-blind results. Psychosomatics 42, 314-319.
15. Bloch, M. R., Landeros-Weisenberger, A., Dombrowski, P., Kelmendi, B., Wegner, R., Nudel, J., Pittenger, C., Leckman, J. F., and Coric, V. (2007). Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol. Psychiatry 62, 839-846.
16. Carries, P., and Delmonico, D. (1996). Childhood abuse and multiple addictions: research findings in a sample of self-identified sexual addicts. Sex. Addict. Compulsivity 3, 258-268.
17. Christenson, G. A., Mackenzie, T. B., Mitchell, J. E., and Callies, A. L. (1991). A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am. J. Psychiatry 148, 1566-1571.
18. Christenson, G. A., Pyle, R., and Mitchell, J. (1991). Estimated lifetime prevalence of trichotillomania in college students. J. Clin. Psychol. 52, 415-417.
19. Coccaro, E. F., (2010). A family history study of intermittent explosive disorder. J. Psychiatr. Res. 44, 1011-1015.
20. Coccaro, E., Lee, R., and Kavoussi, R. (2009). A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J. Clin. Psychol. 70, 653-662.
21. Coccaro, E., Schmidt, C., Samuels, J., and Nestadt, G. (2004). Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J. Clin. Psychol. 65, 820-824.
22. Cohen, L., Stein, D., Simeon, D., Spadaccini, E., Rosen, J., Aronowitz, B., and Hollander, E. (1995). Clinical profile, comorbidity, the treatment history in 123 hair pullers: a survey study. J. Clin. Psychol. 56, 319-326.
23. Coleman, E. (1992). Is your patient suffering from compulsive sexual behavior? Psychiatric Ann. 22, 320-325.
24. Diefenbach, G., Tolin, D., Hannan, S., Crocetto, J., and Worhunsky, P. (2005). Trichotillomania: impact on psychosocial functioning and quality of life. Behav. Res. Ther. 43, 869-884.
25. Fong, T., Kalechstein, A., Bernhard, B., Rosenthal, R., and Rugle, L. (2008). A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol. Biochem. Behav. 89, 298-303.
26. Gambling Impact and Behavior Study. (1999). Report to the National Gambling Impact Study Commission. Chicago, IL: National Opinion Research Center at the University of Chicago. Available at: http://www.norc.uchicago.edu/new/ gamb-fin.htm (accessed July 14, 2010).
27. Grant, J. E. (2008). Impulse Control Disorders: A Clinician's Guide to Understanding and Treating Behavioral Addictions. New York: W.W. Norton & Company.
28. Grant, J. E., and Kim, S. W. (2001). Demographic and clinical features of 131 adult pathological gamblers. J. Clin. Psychiatry 62, 957-962.
29. Grant, J. E., and Kim, S. W. (2002). Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr. Psychiatry 43, 378-384.
30. Grant, J. E., and Kim, S. W. (2007). Clinical characteristics and psychiatric comorbidity of pyromania. J. Clin. Psychol. 68, 1717-1722.
31. Grant, J. E., Kim, S. W., and Hartman, B. (2008). A double-blind, placebocontrolled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J. Clin. Psychiatry 69, 783-739.
32. Grant, J. E., Kim, S. W., and Odlaug, B. L. (2007a). N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol. Psychiatry 62, 652-657.
33. Grant, J. E., Williams, K. A., and Potenza, M. N. (2007b). Impulse-control disorders in adolescent psychiatric inpatients: co-occurring disorders and sex differences. J. Clin. Psychiatry 68, 1584-1592.
34. Grant, J. E., Kim, S. W., and Odlaug, B. L. (2009a). A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol. Psychiatry 65, 600-606.
35. Grant, J. E., Odlaug, B. L., and Kim, S. W. (2009b). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 66, 756-763.
36. Grant, J. E., Kim, S. W., Potenza, M. N., Blanco, C., Ibáñez A., Steven, L., Hektner, J. M., and Zaninelli, R. (2003). Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int. Clin. Psychopharmacol. 18, 243-249.
37. Grant, J. E., Levine, L., Kim, D., and Potenza, M. N. (2005). Impulse control disorders in adult psychiatric inpatients. Am. J. Psychiatry 162, 2184-2188.
38. Grant, J. E., Odlaug, B. L., Chamberlain, S., and Kim, S. W. (2010). A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J. Clin. Psychopharmacol. 30, 396-403.
39. Grant, J. E., Odlaug, B. L., Potenza, M. N., Hollander, E., and Kim, S. W. (2010). Nalmefene in the treatment of pathological gambling: multicentre, doubleblind, placebo-controlled study. Br. J. Psychiatry 197, 330-331.
40. Grant, J. E., and Potenza, M. N. (2004). Pathological Gambling: A Clinical Guide to Treatment. Washington, DC: American Psychiatric Publishing, Inc.
41. Grant, J. E., and Potenza, M. N. (2006). Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int. Clin. Psychopharmacol. 21, 203-209.
42. Grant, J. E., Potenza, M. N., Hollander, E., Cunningham-Williams, R., Nurminen, T., Smits, G., and Kallio, A. (2006). Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am. J. Psychiatry 163, 303-312.
43. Hayes, S. L., Storch, E. A., and Berlanga, L. (2009). Skin picking behaviors: an examination of the prevalence and severity in a community sample. J. Anxiety Disord. 23, 314-319.
44. Holden, C. (2010). Behavioral addictions debut in proposed DSM-V. Science 327, 935.
45. Hollander, E., DeCaria, C., Finkell, J., Begaz, T., Wong, C., and Cartwright, C. (2000). A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol. Psychiatry 47, 813-817.
46. Hollander, E., Pallanti, S., Allen, A., Sood, E., and Rossi, N. (2005). Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am. J. Psychiatry 162, 137-145.
47. Hollander, E., Tracy, K., Swann, A., Coccaro, E. F., McElroy, S. L., Wozniak, P., Sommerville, K. W., and Nemerff, C. B. (2003). Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 28, 1186-1197.
48. Iancu, I., Lowengrub, K., Dembinsky, Y., Kotler, M., and Dannon, P. N. (2008). Pathological gambling: an update on neuropathophysiology and pharmacotherapy. CNS Drugs 22, 123-138.
49. Kafka, M. (2010). Hypersexual disorder: a proposed diagnosis for DSM-V. Arch. Sex. Behav. 39, 377-400.
50. Kafka, M., and Prentky, R. (1992). A comparative study of nonparaphilic sexual addictions and paraphilias in men. J. Clin. Psychiatry 53, 345-350.
51. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K., and Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 593-602.
52. Kessler, R. C., Coccaro, E., Fava, M., Jaeger, S., Jin, R., and Walters, E. (2006). The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63, 669-678.
53. Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N. A., Winters, K. C., and Shaffer, H. J. (2008). The prevalence and correlates of DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol. Med. 38, 1351-1360.
54. Keuthen, N., Koran, L., Aboujaoude, E., Large, M., and Serpe, R. (2010). The prevalence of pathologic skin picking in US adults. Compr. Psychiatry 51, 183-186.
55. Kim, S. W., Grant, J. E., Adson, D., and Shin, Y. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry 49, 914-921.
56. Kim, S. W., Grant, J. E., Adson, D., Shin, Y., and Zaninelli, R. (2002). A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J. Clin. Psychiatry 63, 501-507.
57. Koran, L. M., Aboujaoude, E., and Gamel, N. N. (2007a). Escitalopram treatment of kleptomania: an openlabel trial followed by double-blind discontinuation. J. Clin. Psychiatry 63, 422-427.
58. Koran, L. M., Aboujaoude, E., Solvason, B., Gamel, N., and Smith, E. (2007b). Escitalopram for compulsive buying disorder: a double-blind discontinuation study. J. Clin. Psychopharmacol. 27, 225-227.
59. Koran, L. M., Chuong, H., Bullock, K., and Smith, S. (2003). Citalopram for compulsive shopping disorder: an openlabel study followed by double-blind discontinuation. J. Clin. Psychiatry 64, 793-798.
60. Koran, L. M., Faber, R. J., Aboujaoude, E., Large, M. D., and Serpe, R. T. (2006). Estimated prevalence of compulsive buying behavior in the United States. Am. J. Psychiatry 163, 1806-1812.
61. Lejoyeux, M., Arbaretaz, M., McLoughlin, M., and Adès, J. (2002). Impulse control disorders and depression. J. Nerv. Ment. Dis. 190, 310-314.
62. Lochner, C., Simeon, D., Niehaus, D., and Stein, D. (2002). Trichotillomania and skin-picking: a phenomenological comparison. Depress. Anxiety 15, 83-86.
63. Mattes, J. (2008). Levetiracetam in patients with impulsive aggression: a doubleblind, placebo-controlled trial. J. Clin. Psychol. 69, 310-315.
64. McElroy, S. L., Keck, P. E. Jr., Pope, H. G. Jr., Smith, J. M., and Strakowski, S. M. (1994). Compulsive buying: a report of 20 cases. J. Clin. Psychiatry 55, 242-248.
65. McElroy, S. L., Nelson, E., Welge, J., Kaehler, L., and Keck, P. Jr. (2008). Olanzapine in the treatment of pathological gambling: a negative randomized placebocontrolled trial. J. Clin. Psychiatry 69, 433-440.
66. McElroy, S. L., Pope, H. G. Jr., Hudson, J. I., Keck, P. E. Jr., and White, K. L. (1991). Kleptomania: a report of 20 cases. Am. J. Psychiatry 148, 652-657.
67. McElroy, S. L., Soutullo, C. A., Beckman, D. A., Taylor, P. Jr., and Keck, P. E. Jr. (1998). DSM-IV intermittent explosive disorder: a report of 27 cases. J. Clin. Psychol. 59, 203.
68. McNeilly, D., and Burke, W. (1998). Stealing lately: a case of late-onset kleptomania. Int. J. Geriatr. Psychiatry 3, 116-121.
69. Miltenberger, R. G., Rapp, J., and Long, E. (2006). "Characteristics of trichotillomania," in Tic Disorders, Trichotillomania, and Other Repetitive Behavior Disorders, eds D. W. Woods and R. G. Miltenberger (New York, NY: Springer), 133-150.
70. Ninan, P., McElroy, S., Kane, C. P., Knight, B. T., Casuto, L. S., Rose, S. E., Marsteller, F. A., and Nemeroff, C. B. (2000a). Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. J. Clin. Psychopharmacol. 20, 362-366.
71. Ninan, P., Rothbaum, B., Marsteller, F., Knight, B., and Eccard, M. (2000b). A placebo-controlled trial of cognitivebehavioral therapy and clomipramine in trichotillomania. J. Clin. Psychiatry 61, 47-50.
72. Odlaug, B. L., and Grant, J. E. (2008a). Trichotillomania and pathological skin picking: clinical comparison with an examination of comorbidity. Ann. Clin. Psychiatry 20, 57-63.
73. Odlaug, B. L., and Grant, J. E. (2008b). Clinical characteristics and medical complications of pathologic skin picking. Gen. Hosp. Psychiatry 30, 61-66.
74. Odlaug, B. L., and Grant, J. E. (2010). Impulse-control disorders in a college sample: results from the selfadministered Minnestoa Impulse Disorders Interview (MIDI). Prim. Care Companion J. Clin. Psychiatry 12, e1-e5.
75. O'Sullivan, R., Christenson, G., and Stein, D. (1999). "Pharmacotherapy of trichotillomania," in Trichotillomania, eds D. Stein, G. Christenson, and E. Hollander (Washington, DC: American Psychiatric Press), 93-124.
76. Petry, N. M., and Kiluk, B. (2002). Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J. Nerv. Ment. Dis. 190, 462-469.
77. Petry, N. M., Stinson, F. S., and Grant, B. F. (2005). Comorbidty of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 66, 564-574.
78. Phelan, J. E. (2002). Childhood kleptomania: two clinical case studies with implications for further research. Psychol. Educ. 39,19-21.
79. Potenza, M. (2006). Should addictive disorders include non-substance related conditions. Addiction 101(Suppl. 1), 142-151.
80. Repo, E., Virkkunen, M., Rawlings, R., and Linnoila, M. (1997). Criminal and psychiatric histories of Finnish arsonists. Acta Psychiatr. Scand. 95, 318-323.
81. Sáiz-Ruiz, J., Blanco, C., Ibáñez, A., Masramon, X., Gomez, M. M., Madrigal, M., and Diez, T. (2005). Sertraline treatment of pathological gambling: a pilot study. J. Clin. Psychiatry 66, 28-33.
82. Schlosser, S., Black, D. W., Repertinger, S., and Freet, D. (1994). Compulsive buying: demography, phenomenology, and comorbidity in 46 subjects. Gen. Hosp. Psychiatry 16, 205-212.
83. Schlueter, G. R., O'Neal, F. C., Hickey, J., and Seiler, G. L. (1989). Rational vs. nonrational shoplifting types: the implications for loss prevention strategies. Int. J. Offender Ther. Comp. Criminol. 33, 227-229.
84. Schneider, J., and Schneider, B. (1996). Couple recovery from sexual addiction/ co addiction: results of a survey of 88 marriages. Sex. Addict. Compulsivity 3, 111-126.
85. Simeon, D., Stein, D., Gross, S., Islam, N., Schmeidler, J., and Hollander, E. (1997). A double-blind trial of fluoxetine in pathologic skin picking. J. Clin. Psychiatry 58, 341-347.
86. Stein, D. J., Grant, J. E., Franklin, M. E., Keuthen, N., Lochner, C., Singer, H. S., and Woods, D. W. (2010). Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movent disorder: toward DSM-V. Depress. Anxiety 27, 611-626.
87. Streichenwein, S., and Thornby, J. (1995). A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am. J. Psychiatry 152, 1192-1196.
88. Swedo, S., Leonard, H., Rapoport, J., Lenane, M., Goldberger, E., and Cheslow, D. (1989). A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N. Engl. J. Med. 321, 497-501.
89. Toneatto, T., Brands, B., and Selby, P. (2009). A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. Am. J. Addict. 18, 219-225.
90. Van Amerigen, M., Mancini, C., Patterson, B., Bennett, M., and Oakman, J. (2010). A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J. Clin. Psychiatry 71, 1336-1343.
91. Van Minnen, A., Hoogduin, K., Keijsers, G., Hellenbrand, I., and Hendriks, G. (2003). Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch. Gen. Psychiatry 60, 517-522.
92. Wainberg, M., Muench, F., Morgenstern, J., Hollander, E., Irwin, T. W., Parsons, J. T., Allen, A., and O'Leary, A. (2006). A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J. Clin. Psychiatry 67, 1968-1973.
93. Woods, D. W., Flessner, C. A., Franklin, M. E., Keuthen, N. J., Goodwin, R. D., Stein, D. J., Walther, M. R., and the Trichotillomania Learning Center-Scientific Advisory Board. (2006). The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J. Clin. Psychol. 67, 1877-1888.